Loading…
Alterity Therapeutics Limited is projected to rise to $7.17 by 2027, a +32% move from its current price of $5.43. ATHE is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $5.23 | $5.43 | $5.65 | +0.08% |
| Jul 13 | $5.15 | $5.44 | $5.74 | +0.16% |
| Jul 14 | $5.09 | $5.44 | $5.82 | +0.24% |
| Jul 15 | $5.05 | $5.45 | $5.88 | +0.33% |
| Jul 16 | $5.00 | $5.45 | $5.94 | +0.41% |
| Jul 17 | $4.97 | $5.46 | $5.99 | +0.49% |
| Jul 18 | $4.94 | $5.46 | $6.04 | +0.57% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.94 | $5.46 | $6.04 | +0.57% |
| Week 2 | $4.76 | $5.49 | $6.34 | +1.14% |
| Week 3 | $4.64 | $5.52 | $6.58 | +1.72% |
| Week 4 | $4.54 | $5.55 | $6.80 | +2.30% |
| Week 5 | $4.45 | $5.59 | $7.01 | +2.88% |
| Week 6 | $4.38 | $5.62 | $7.20 | +3.47% |
| Week 7 | $4.32 | $5.65 | $7.39 | +4.06% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Alterity Therapeutics Limited is a healthcare company focused on research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The lead drug candidate is ATH434, a small molecule that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, ATH434-202 and biomarkers of progression for MSA, all in Phase II clinical trials.
The company also operates a drug discovery platform that generates patentable chemical compounds to treat the underlying pathology of neurological diseases.
Alterity Therapeutics Limited (ATHE) is a healthcare company with a current price of $5.38 per share and a market capitalization of $97.52M. It is ranked 4235 in market capitalization. The forecast implies a long-run price pathway with varying annual averages and upside potential across 2026 to 2050, including a 2026 average of $5.38 and a steep rise in subsequent years.
A major floor 43.2% below — a decisive break under it would weaken the trend.
The nearest floor, 28.2% below — buyers have tended to step in here.
The nearest ceiling, 8.5% above — a clean break opens room to run.
A major ceiling 30.1% above — clearing it would confirm fresh momentum.
Key ATHE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ATHE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.55 | Sell | $5.45 | Sell |
| MA 10 | $5.37 | Buy | $5.35 | Buy |
| MA 20 | $5.05 | Buy | $5.10 | Buy |
| MA 50 | $4.61 | Buy | $4.68 | Buy |
| MA 100 | $4.15 | Buy | $4.34 | Buy |
| MA 200 | $3.92 | Buy | $4.10 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.18 | Neutral |
| Stoch RSI (14) | 9.21 | Buy |
| CCI (20) | 69.01 | Neutral |
| Williams %R (14) | -42.99 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 9.48 | Buy |
| Bollinger %B (20,2) | 0.71 | Neutral |
| Stochastic %K (14) | 57.01 | Neutral |
| TRIX (15) | 0.91 | Buy |
| Awesome (5,34) | 0.91 | Buy |
| Ultimate (7,14,28) | 56.45 | Neutral |
| Momentum (10) | 0.53 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 5.52 | Sell |
| ADX (14) | 24.96 | Buy |
| ATR (14) | 0.17 | Info |
The 30-day technical picture is bullish. The RSI14 stands at 60, with the 50-day simple moving average at $4.59 and the 200-day simple moving average at $3.92. Near-term support is at $3.90 and resistance at $5.89, framing a 30-day price range from $4.15 to $6.98. Annualized volatility is 80.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.02 | $5.43 | $7.84 | 0% | Neutral | |
| $5.50 | $7.17 | $10.02 | +32% | Bullish | |
| $7.24 | $9.84 | $14.44 | +81% | Bullish | |
| $10.20 | $14.35 | $21.86 | +164% | Bullish | |
| $11.14 | $16.15 | $25.40 | +198% | Bullish | |
| $11.84 | $17.66 | $28.55 | +225% | Bullish | |
| $13.33 | $20.42 | $33.82 | +276% | Bullish | |
| $13.24 | $20.80 | $35.21 | +283% | Bullish | |
| $15.57 | $25.05 | $43.27 | +361% | Bullish | |
| $19.20 | $31.61 | $55.64 | +482% | Bullish | |
| $28.06 | $51.45 | $97.85 | +847% | Bullish | |
| $62.79 | $139.53 | $296.49 | +24.7x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $3.02 | $5.43 | $6.87 | +0.00% |
| August 2026 | $4.98 | $5.95 | $7.33 | +9.51% |
| September 2026 | $4.85 | $5.85 | $7.32 | -1.66% |
| October 2026 | $4.88 | $5.93 | $7.52 | +1.39% |
| November 2026 | $5.06 | $6.20 | $7.94 | +4.50% |
| December 2026 | $4.92 | $6.06 | $7.84 | -2.18% |
Click any year to see its month-by-month ATHE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ATHE price prediction for 2026 points to an average of $5.43 (low $3.02, high $7.84) — a potential gain of 0% on today's $5.43. A consolidation phase looks the most probable path here.
In 2027, ATHE is projected to trade between $5.50 and $10.02, averaging $7.17 — a potential gain of +32% from today's $5.43. That is up +32% on the projected 2026 average. Momentum favours further upside here.
Alterity Therapeutics Limited's 2028 outlook centres on $9.84, within a $7.24 to $14.44 range. That is up +37% on the projected 2027 average. That marks a +81% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, ATHE could reach as high as $21.86, with a base case around $14.35 and support toward $10.20 — roughly +164% from $5.43. Momentum favours further upside here.
Expect ATHE to range from $11.14 to $25.40 through 2030. The $16.15 average target implies a +198% move from current prices. That is up +13% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The ATHE price prediction for 2031 points to an average of $17.66 (low $11.84, high $28.55) — a potential gain of +225% on today's $5.43. Momentum favours further upside here.
In 2032, ATHE is projected to trade between $13.33 and $33.82, averaging $20.42 — a potential gain of +276% from today's $5.43. That is up +16% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Alterity Therapeutics Limited's 2033 outlook centres on $20.80, within a $13.24 to $35.21 range. That is up +2% on the projected 2032 average. That marks a +283% change versus current levels. Momentum favours further upside here.
By 2034, ATHE could reach as high as $43.27, with a base case around $25.05 and support toward $15.57 — roughly +361% from $5.43. Buyers look set to stay in control over this stretch.
Expect ATHE to range from $19.20 to $55.64 through 2035. The $31.61 average target implies a +482% move from current prices. That is up +26% on the projected 2034 average. Momentum favours further upside here.
The ATHE price prediction for 2040 points to an average of $51.45 (low $28.06, high $97.85) — a potential gain of +847% on today's $5.43. Buyers look set to stay in control over this stretch.
In 2050, ATHE is projected to trade between $62.79 and $296.49, averaging $139.53 — a potential gain of +24.7x from today's $5.43. That is up +171% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ATHE today (≈ 184.162063 ATHE) could be worth
$25,696.86
+$24,696.86 (+2470%) by 2050 · US Dollar
Based on the average projected ATHE price of $139.53 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ATHEwould be worth at today's price.
$1,000 invested in ATHE on Jul 10, 2025 (≈ 257.069402 ATHE) would be worth
$1,395.89
+$395.89 (+39.6%) today · 1.40× · US Dollar
Based on a ATHE entry price of $3.89 vs. today's $5.43.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.36 | $1,013.06 | +1.3% |
| 1 month ago | $4.15 | $1,308.43 | +30.8% |
| 3 months ago | $3.72 | $1,459.68 | +46.0% |
| 6 months ago | $3.52 | $1,542.61 | +54.3% |
| 1 year ago | $3.89 | $1,395.89 | +39.6% |
| All time (5.0y) ago | $15.5 | $350.32 | -65.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ATHE forecast.
Our base-case forecast reaches $11.00 around 2029.
Implied market cap at $11.00: $199.38M
The multi-year forecast shows a bullish arc beginning in the later years and running through 2050. In 2026, the min is $3.02, the avg $5.38, the max $7.78, with a 0 ROI and neutral sentiment. In 2027, the avg rises to $7.10 with a max of $9.96 and ROI of 31.9, sentiment Bullish.
The path continues higher with 2028 avg $9.78, 2029 avg $14.31, and 2030 avg $16.13, with corresponding max values and rising ROI (81.8, 166, and 199.8 respectively). By 2035 the avg is $31.43 and max $55.90 with ROI 484.1 and Bullish sentiment. The forecast then projects 2040 with avg $51.32 and max $98.78 (ROI 853.9) and 2050 with avg $139.41 and max $300.35 (ROI 2491.3), both Bullish.
These figures illustrate a long-run upside potential but remain estimates with inherent uncertainty and are not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows min $11.03, avg $16.13, max $25.57, ROI 199.8, sentiment Bullish.
The forecast shows bullish sentiment from 2027 onward with rising averages and ROI, including 31.9 in 2027, 81.8 in 2028, 166 in 2029, 199.8 in 2030, and up to 2491.3 by 2050.
The 2040 max is $98.78 (below 100), while the 2050 max is $300.35 (above 100), so reaching $100 is possible within the forecast horizon.
Current price is $5.38 and market cap is $97.52M.
Sentiment is BULLISH; RSI14 is 60; SMA50 is $4.59; SMA200 is $3.92; support is $3.90 and resistance is $5.89. The 30-day range is $4.15 to $6.98 and annualized volatility is 80.
Alterity Therapeutics Limited Community Discussion
0Share your Alterity Therapeutics Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.